- Release Date: 18/10/21 09:48
- Summary: Remestemcel-L Improves Survival in High-Risk Acute GvHD
- Price Sensitive: No
- Download Document 189.84KB
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.008(0.72%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.04 | $2.433M | 2.310M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 43324 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 35210 | 23 |
View Market Depth
| Last trade - 13.03pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
0.008 ( 1.11 %) |
||||
| Open | High | Low | Volume | ||
| $1.04 | $1.07 | $1.04 | 433620 | ||
| Last updated 13.15pm 14/05/2024 ? | |||||
| MSB (ASX) Chart |